全文获取类型
收费全文 | 429篇 |
免费 | 29篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 5篇 |
妇产科学 | 14篇 |
基础医学 | 57篇 |
口腔科学 | 9篇 |
临床医学 | 57篇 |
内科学 | 83篇 |
皮肤病学 | 9篇 |
神经病学 | 21篇 |
特种医学 | 4篇 |
外科学 | 40篇 |
综合类 | 10篇 |
一般理论 | 1篇 |
预防医学 | 40篇 |
眼科学 | 6篇 |
药学 | 53篇 |
中国医学 | 16篇 |
肿瘤学 | 30篇 |
出版年
2023年 | 10篇 |
2022年 | 4篇 |
2021年 | 12篇 |
2020年 | 9篇 |
2019年 | 12篇 |
2018年 | 12篇 |
2017年 | 11篇 |
2016年 | 13篇 |
2015年 | 27篇 |
2014年 | 30篇 |
2013年 | 20篇 |
2012年 | 30篇 |
2011年 | 35篇 |
2010年 | 18篇 |
2009年 | 11篇 |
2008年 | 17篇 |
2007年 | 31篇 |
2006年 | 24篇 |
2005年 | 26篇 |
2004年 | 21篇 |
2003年 | 21篇 |
2002年 | 19篇 |
2001年 | 5篇 |
2000年 | 3篇 |
1999年 | 11篇 |
1998年 | 3篇 |
1997年 | 3篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1988年 | 1篇 |
1985年 | 8篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1975年 | 1篇 |
1971年 | 1篇 |
1969年 | 2篇 |
1968年 | 3篇 |
1967年 | 1篇 |
1965年 | 2篇 |
排序方式: 共有464条查询结果,搜索用时 10 毫秒
101.
102.
Morphine is known to inhibit nocturnal uterine contractions in several animal models, and oxytocin is known to be a primary causative factor of uterine contractions. The purpose of the present study was to determine the tocolytic effect of morphine in relation to the pharmacokinetics of oxytocin, after a bolus injection of oxytocin. The metabolism of oxytocin was investigated during the third trimester in baboons. Four animals were placed on a tether system with venous and arterial access, including continuous uterine monitoring. Plasma oxytocin levels were determined by radioimmunoassay after extraction with petroleum ether/acetone. Morphine consistently increased the metabolic clearance rate of oxytocin in all four animals (p < 0.05) and this was in accordance with suppressed uterine contractions. We conclude that morphine could be used as an inhibitor of nocturnal uterine contractions, and that this is caused by the morphine induced increased metabolic clearance rate of oxytocin. 相似文献
103.
Young Seok Kim Eun Sun Jung Wonhee Hur Si Hyun Bae Jong Young Choi Myeong Jun Song Chang Wook Kim Se Hyun Jo Chang Don Lee Young Sok Lee Sang Wook Choi Jin Mo Yang Jeong Won Jang Sang Gyune Kim Seung Won Jung Hee Kyung Kim Hee Bok Chae Seung Kew Yoon 《Clinical and molecular hepatology》2013,19(2):120-130
Background/Aims
The aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver disease (NAFLD), and (2) to determine whether the levels of the identified parameters are correlated with the severity of liver injury in patients with NASH.Methods
One hundred and eight consecutive patients with biopsy-proven NAFLD (age, 39.8±13.5 years, mean±SD; males, 67.6%) were prospectively enrolled from 10 participating centers across Korea.Results
According to the original criteria for NAFLD subtypes, 67 patients (62.0%) had NASH (defined as steatosis with hepatocellular ballooning and/or Mallory-Denk bodies or fibrosis ≥2). Among those with NAFLD subtype 3 or 4, none had an NAFLD histologic activity score (NAS) below 3 points, 40.3% had a score of 3 or 4 points, and 59.7% had a score >4 points. Fragmented cytokeratin-18 (CK-18) levels were positively correlated with NAS (r=0.401), as well as NAS components such as lobular inflammation (r=0.387) and ballooning (r=0.231). Fragmented CK-18 was also correlated with aspartate aminotransferase (r=0.609), alanine aminotransferase (r=0.588), serum ferritin (r=0.432), and the fibrosis stage (r=0.314). A fragmented CK-18 cutoff level of 235.5 U/L yielded sensitivity, specificity, and positive and negative predictive values of 69.0%, 64.9%, 75.5% (95% CI 62.4-85.1), and 57.1% (95% CI 42.2-70.9), respectively, for the diagnosis of NASH.Conclusions
Serum fragmented CK-18 levels can be used to distinguish between NASH and NAFL. Further evaluation is required to determine whether the combined measurement of serum CK-18 and ferritin levels improves the diagnostic performance of this distinction. 相似文献104.
105.
Yukmijihwangtang (YM), a boiled extract of medicinal plants, has been prescribed for patients with kidney dysfunction in Korea; however, the mechanism underlying its therapeutic effects has not been fully elucidated. This study was conducted to evaluate the beneficial effects on bladder function by using modified YM (M-YM), which included Ulmi radicis cortex in addition to the six traditional medicinal plants in YM. Bladder irritation of the rats was caused by intravesical instillation of HCl. The animals were divided into six groups: sham group, cystitis-injury group with no treatment, cystitis-injury group with prednisolone treatment (5 mg/kg), and cystitis-injury with M-YM treatment (100, 200 or 500 mg/kg groups). Whole bladders were collected at day eight after injury. Samples were analyzed by histological and immunological examinations. An in vitro study was performed to determine whether M-YM extracts inhibit lipopolysaccharide (LPS)-induced nitric oxide (NO) production and IκB phosphorylation in a human uroepithelial cell line of T24 cells. Administration of M-YM notably improved bladder histological changes, and suppressed IL-6/TNF α production and IκB phosphorylation in a rat model of chronic cystitis. M-YM also inhibited LPS-induced NO production and IκB phosphorylation in T24 cells. This study suggests that administration of M-YM might be an applicable therapeutic traditional medicine for the treatment of interstitial cystitis. 相似文献
106.
107.
Jang Yuri Park Nan Sook Chiriboga David A. Yoon Hyunwoo An Sok Kim Miyong T. 《Journal of cross-cultural gerontology》2015,30(2):131-141
Journal of Cross-Cultural Gerontology - This study examined how social capital in ethnic communities (e.g., social cohesion, community support, community participation, and negative interaction)... 相似文献
108.
Hyun Jin An Kyung Hyun Kim Woo Ram Lee Jung Yeon Kim Sun Jae Lee Sok Cheon Pak Sang Mi Han Kwan Kyu Park 《Toxins》2015,7(6):1917-1928
Progressive renal fibrosis is the final common pathway for all kidney diseases leading to chronic renal failure. Bee venom (BV) has been widely used as a traditional medicine for various diseases. However, the precise mechanism of BV in ameliorating the renal fibrosis is not fully understood. To investigate the therapeutic effects of BV against unilateral ureteral obstruction (UUO)-induced renal fibrosis, BV was given intraperitoneally after ureteral ligation. At seven days after UUO surgery, the kidney tissues were collected for protein analysis and histologic examination. Histological observation revealed that UUO induced a considerable increase in the number of infiltrated inflammatory cells. However, BV treatment markedly reduced these reactions compared with untreated UUO mice. The expression levels of TNF-α and IL-1β were significantly reduced in BV treated mice compared with UUO mice. In addition, treatment with BV significantly inhibited TGF-β1 and fibronectin expression in UUO mice. Moreover, the expression of α-SMA was markedly withdrawn after treatment with BV. These findings suggest that BV attenuates renal fibrosis and reduces inflammatory responses by suppression of multiple growth factor-mediated pro-fibrotic genes. In conclusion, BV may be a useful therapeutic agent for the prevention of fibrosis that characterizes progression of chronic kidney disease. 相似文献
109.
Kyung-Hyun Kim Hyun-Jung Sung Woo-Ram Lee Hyun-Jin An Jung-Yeon Kim Sok Cheon Pak Sang-Mi Han Kwan-Kyu Park 《Toxins》2015,7(9):3372-3387
Cholangiopathy is a chronic immune-mediated disease of the liver, which is characterized by cholangitis, ductular reaction and biliary-type hepatic fibrosis. There is no proven medical therapy that changes the course of the disease. In previous studies, melittin was known for attenuation of hepatic injury, inflammation and hepatic fibrosis. This study investigated whether melittin provides inhibition on cholangitis and biliary fibrosis in vivo. Feeding 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) to mice is a well-established animal model to study cholangitis and biliary fibrosis. To investigate the effects of melittin on cholangiopathy, mice were fed with a 0.1% DDC-containing diet with or without melittin treatment for four weeks. Liver morphology, serum markers of liver injury, cholestasis markers for inflammation of liver, the degree of ductular reaction and the degree of liver fibrosis were compared between with or without melittin treatment DDC-fed mice. DDC feeding led to increased serum markers of hepatic injury, ductular reaction, induction of pro-inflammatory cytokines and biliary fibrosis. Interestingly, melittin treatment attenuated hepatic function markers, ductular reaction, the reactive phenotype of cholangiocytes and cholangitis and biliary fibrosis. Our data suggest that melittin treatment can be protective against chronic cholestatic disease in DDC-fed mice. Further studies on the anti-inflammatory capacity of melittin are warranted for targeted therapy in cholangiopathy. 相似文献